2023-11-03 - LD Munich - Amgen v. Sanofi et al. - UPC_CFI_14/2023

Aktenzeichen:
UPC_CFI_14/2023
Datum:
Spruchkörper:
Court of First Instance - Munich (DE) Local Division
Art:
Order
Parteien:
Amgen, Inc. v. Sanofi-Aventis Deutschland GmbH

Kernaussage: Verfahrenssprache

2023-11-03 - LD Munich - Amgen v. Sanofi et al. - UPC_CFI_14/2023
🏛️Court of First Instance - Munich (DE) Local Division• Order
📅2023-11-03
🔢UPC_CFI_14/2023
Parteien & Vertreter
Kläger / Berufungsführer
Amgen Inc.
Johannes HESELBERGER
Beklagter / Berufungsbeklagter
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Groupe S.A.
Sanofi Winthrop Industrie S.A.
Regeneron Pharmaceuticals Inc.
Niels HOELDER
📋ORD_584907/2023
⚖️Infringement Action
🌐German
🤖🇬🇧

Verfahrenssprache

routine
The Munich LD (full panel including a TQJ) granted a R. 322 RoP / Art. 49(4) UPCA change of the language of proceedings from German to English, i.e. the language in which the patent (EP 3 666 797) was granted. The procedure was initiated informally by defendants' counsel by email, a formal proposal issued by the judge-rapporteur after confirming that all panel members supported the change, and both parties then formally consented via the CMS. The claimant undertook to file an English translation of the statement of claim within two months, and the defendants were directed to file their imminent statement of defence directly in English; exhibits already in German or English need not be translated.
Stichwörter
Rule 322

Inoffiziell

Entscheidung teilen

Weitere Navigation
Entscheidungen
Rechtstexte
Analysen

Zu Sammlung hinzufügen

0 Einträge hinzufügen zu:

Anmeldung

Registrieren